UNSPSC 51442402: Adipiodone or iodipamide

This classification denotes an iodinated contrast dye (especially used in liver CT studies) with the molecular formula C20H14I6N2O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TKQ858A3VW, chemically known as 3,3-(adipoyldiimino)bis(2,4,6-triiodobenzoic acid) but more generally known as adipiodone, which bears U.S. National Institutes of Health Compound Identifier 3739. Adipiodone most often comes in forms base and meglumine.

UNSPSC 51442402 Adipiodone or iodipamide is a Commodity code that nominally identifies a contrast medium chemical compound, but recent state and local procurement activity under this code shows little alignment with medical imaging supplies. The issuing bodies posting opportunities tagged to this code are primarily county-level government entities, though the actual work being solicited — maintenance services for X-ray inspection systems and chemical supplies for water treatment — does not correspond to the adipiodone product category. Broward County Aviation Department and Pasco County are the visible repeat buyers in recent activity, but their procurement needs reflect broader facility and operations management rather than the specific pharmaceutical or medical contrast category the code nominally describes.

Activity appears concentrated in Florida, with both recent opportunities (Broward County and Pasco County) originating there. Broward County Aviation Department posted an RFI on June 25, 2026, with responses due July 28, 2026, seeking to establish whether maintenance and repair services for Rapiscan X-ray inspection systems—600 series, 900 series, VOTI XR3D, and Gemini systems—are available from vendors other than Rapiscan or whether comparable systems exist. Pasco County issued an RFQ on June 3, 2026, with proposals due June 26, 2026, for as-needed supply of large copper sulfate crystals and liquid copper sulfate. The code shows no recent procurement activity that directly involves adipiodone or contrast media compounds, suggesting either sparse state and local demand for this specific chemical or a systematic mislabeling issue in how these opportunities are tagged at the source.